Literature DB >> 18500459

A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin receptor antibodies.

Yuuka Kato1, Yoshiro Ichiki, Yasuo Kitajima.   

Abstract

We describe herein a patient with hypoglycemia due to anti-insulin receptor antibodies in systemic lupus erythematosus (SLE). A 40-year-old Japanese woman with a 10-year follow-up for SLE was admitted with hypoglycemia. Her blood test revealed the presence of anti-insulin receptor antibody, normal level of insulin and C-peptide, and negative for anti-insulin antibody. Her symptoms responded well to the therapy of predonisolone (30 mg/day) and continuous intravenous glucose as anti-insulin receptor antibody became negative. We emphasize here the significance of these antibodies in complicating the SLE-associated hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500459     DOI: 10.1007/s00296-008-0617-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.

Authors:  Elif Arioglu; Alexa Andewelt; Crystal Diabo; Melissa Bell; Simeon I Taylor; Phillip Gorden
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

Review 2.  [Anti-insulin receptor antibody and insulin resistance].

Authors:  M Kobayashi
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1992-01-20

3.  Successful treatment of Type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus.

Authors:  A P Coll; D Morganstein; D Jayne; M A Soos; S O'Rahilly; J Burke
Journal:  Diabet Med       Date:  2005-06       Impact factor: 4.359

4.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

Authors:  C R Kahn; J S Flier; R S Bar; J A Archer; P Gorden; M M Martin; J Roth
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

Review 5.  Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus.

Authors:  D E Moller; R E Ratner; D G Borenstein; S I Taylor
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

6.  The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions.

Authors:  E D Rosenstein; S Advani; R E Reitz; N Kramer
Journal:  J Clin Rheumatol       Date:  2001-12       Impact factor: 3.517

7.  Hypoglycemia due to antiinsulin receptor antibodies in systemic lupus erythematosus.

Authors:  J Varga; M Lopatin; G Boden
Journal:  J Rheumatol       Date:  1990-09       Impact factor: 4.666

Review 8.  Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease.

Authors:  E J Feinglass; F C Arnett; C A Dorsch; T M Zizic; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1976-07       Impact factor: 1.889

9.  Type B insulin resistance syndrome induced by increased activity of systemic lupus erythematosus in a hemodialysis patient.

Authors:  Y Nagayama; H Morita; D Komukai; S Watanabe; A Yoshimura
Journal:  Clin Nephrol       Date:  2008-02       Impact factor: 0.975

10.  Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.

Authors:  Gilbert G Fareau; Mario Maldonado; Elif Oral; Ashok Balasubramanyam
Journal:  Metabolism       Date:  2007-05       Impact factor: 8.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.